BioGaia AB Ser. B
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioGaia AB Ser. B
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.
Frequently asked questions
To buy BioGaia AB Ser. B stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioGaia AB Ser. B by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioGaia AB Ser. B is BIOG_B:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioGaia AB Ser. B has its primary listing on NASDAQ OMX Stockholm. You can trade BioGaia AB Ser. B with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioGaia AB Ser. B is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioGaia AB Ser. B as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioGaia AB Ser. B.